Statistics

Total Visits

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by43

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by21

Views

Views
June 202510
July 20252
August 20252
September 20252
October 20250
November 20254
December 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong9
United States4
Argentina2
Brazil1
Canada1
Germany1
United Kingdom1
Mexico1
Peru1
 

Top cities views

Views
Hong Kong9
Los Angeles2
Ashburn1
Calgary1
Frankfurt am Main1
Lanús1
Lima1
Mexico City1
San Lorenzo1
São Paulo1